CVS Health reports first quarter results

Key financial data

First quarter highlights

• Total revenues increased to $85.3 billion, up 11.0% compared to prior year
• GAAP diluted EPS of $1.65 and Adjusted EPS of $2.20
• Generated cash flow from operations of $7.4 billion

Note: Financial information for the three months ended March 31, 2022 throughout this press release has been revised to conform with certain current period financial statement changes as described on page 2

2023 Full-year guidance

• Revised GAAP diluted EPS guidance range to $6.90 to $7.12 from $7.73 to $7.93
• Revised Adjusted EPS guidance range to $8.50 to $8.70 from $8.70 to $8.90
• Confirmed cash flow from operations guidance range of $12.5 billion to $13.5 billion

CEO commentary

“We delivered another strong quarter while executing on the strategy we outlined in December 2021, leading to the close of the Signify Health acquisition followed…